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A change in the zinc ion 
concentration reflects the 
maturation of insulin-producing 
cells generated from adipose-
derived mesenchymal stem cells
Shogo ohta  , Tetsuya ikemoto  *, Yuma Wada  , Yu Saito, Shinichiro Yamada, 
Satoru imura, Yuji Morine & Mitsuo Shimada
The generation of insulin-producing cells (IPCs) from pluripotent stem cells could be a breakthrough 
treatment for type 1 diabetes. However, development of new techniques is needed to exclude 
immature cells for clinical application. Dithizone staining is used to evaluate IPCs by detecting zinc. We 
hypothesised that zinc ion (Zn2+) dynamics reflect the IPC maturation status. Human adipose-derived 
stem cells were differentiated into IPCs by our two-step protocol using two-dimensional (2D) or 3D 
culture. The stimulation indexes of 2D -and 3D-cultured IPCs on day 21 were 1.21 and 3.64 (P < 0.05), 
respectively. The 3D-cultured IPCs were stained with dithizone during culture, and its intensity 
calculated by ImageJ reached the peak on day 17 (P < 0.05). Blood glucose levels of streptozotocin-
induced diabetic nude mice were normalised (4/4,100%) after transplantation of 96 3D-cultured IPCs. 
Zn2+ concentration changes in the medium of 3D cultures had a negative value in the early period 
and a large positive value in the latter period. This study suggests that Zn2+ dynamics based on our 
observations and staining of zinc transporters have critical roles in the differentiation of IPCs, and that 
their measurement might be useful to evaluate IPC maturation as a non-destructive method.
The generation of insulin producing cells (IPCs) derived from pluripotent stem cells (PSCs) has the possibility 
to resolve the issue of donor shortages for islet transplantation in some countries1. Many studies have investi-
gated the induction of IPCs from PSCs, such as embryonic stem cells, induced pluripotent stem cells, and other 
organ-derived cells2–11. In particular, adipose-derived stem cells (ADSCs) can be procured less invasively and 
without ethical problems compared with some types of PSCs12. An advantage of ADSCs is that up to 300-fold 
more stem cells can be obtained from the same quantity of bone marrow aspiration13. Moreover, they might be 
easy to apply clinically because such cell transplantation is considered auto-transplantation that does not require 
immunosuppression. Thus, we focused on ADSCs as a new cell source for IPCs12,14,15. We have previously reported 
a new two-step differentiation protocol16 and its modification to a more effective xeno-free and three-dimensional 
culture protocol17 to generate functional IPCs from ADSCs. For clinical application, it is important to exclude 
immature IPCs. Moreover, IPC maturation has been induced in vivo at a few months after transplantation3,18. 
Thus, the best timing for IPC transplantation is still unclear.
The role of the zinc ion (Zn2+) in pancreatic β-cells is important for basic cell structures and enzymes. 
Mammalian pancreatic β-cells contain higher levels of intracellular Zn2+ than other organs19. In β-cells, insulin 
binds to Zn2+ and is converted into a hexamer within secretory granules20. Then, Zn2+ is released with insulin and 
absorbed by β-cells again. Therefore, mature β-cells both take up and Zn2+ secrete21,22. Dithizone staining is used 
to detect islets by the presence of high density Zn2+, which can be applied to evaluate IPCs8,16,20. However, cells 
are destroyed by the toxicity of dithizone in this procedure, and it is dangerous to use dithizone clinically because 
of its carcinogenicity8,20.
Department of Digestive and Transplant Surgery, Tokushima University, 3-18-15 Kuramoto, Tokushima, 770-8503, 
Japan. *email: ikemoto.tetsuya@tokushima-u.ac.jp
open
2Scientific RepoRtS |         (2019) 9:18731  | https://doi.org/10.1038/s41598-019-55172-0
www.nature.com/scientificreportswww.nature.com/scientificreports/
Zn2+ is an important metal ion related to a variety of metabolic functions. For example, DNA and RNA poly-
merases, which are necessary for cell proliferation, gene expression, and matrix metalloproteases, which operate 
in cell migration and invasion, are Zn2+-dependent enzymes23–25.
It has been hypothesised that Zn2+ might be absorbed for cell activity during differentiation and maturation, 
and secreted with insulin upon maturation. Therefore, Zn2+ dynamics in differentiated cells are considered as the 
novel marker for the maturation of generated IPCs.
Here, we determined whether the Zn2+ concentration in culture medium is an easy and useful marker of IPC 
differentiation and maturation, and demonstrate the mechanism of Zn2+ dynamics of IPCs.
Results
IPCs in 3D culture form cell clusters more easily than in conventional 2D culture. During two-
step differentiation, there were some morphological differences between the conventional 2D culture and 3D 
culture due to the culture duration. In detail, in the 3D culture, ADSCs and RCP pieces gathered and underwent 
sphere-like formation within 24 hours of culture (Fig. 1A). Subsequently, IPCs generated in 3D culture exhibited 
sphere-like formations until 21 days, whereas cell clusters had formed at around day 21 in conventional 2D cul-
ture (Fig. 1B). Immunofluorescence staining detected human insulin in the cytoplasm of 3D-cultured IPCs on 
day 21 (Fig. 1C). These culture method-related differences revealed that the stimulation index (SI) was signifi-
cantly higher in 3D-cultured IPCs compared with conventional 2D culture on day 21 (3.64 ± 0.86 vs. 1.21 ± 0.11, 
P < 0.05, Welch’s test, Fig. 1D). Measured insulin concentrations including under the non-stimulated (basal) 
condition of each culture system are shown in Table 1.
3D-cultured IPCs reduce blood glucose levels of DM mice after transplantation. As an in vivo 
functional assay, after transplantation of 96 3D-cultured IPCs into the mesentery of STZ-induced DM nude mice 
(n = 4), blood glucose levels gradually decreased below 200 mg/dl. Briefly, at 6 days after transplantation, the 
Figure 1. (A) ADSCs formed cell clusters within 24 hours after adding RCPγ pieces. Original magnification 
x40. (B) Cell cluster-like formation required more time in conventional 2D culture (upper row, original 
magnification x100) compared with 3D culture (lower row, original magnification x40). (C) Stimulation index 
of 3D-cultured IPCs was significantly higher than that of 2D-cultured IPCs on day 21 (*P = 0.004, Welch’s test). 
(D) Mature IPCs expressed insulin strongly according to immunofluorescence staining. Day 21, 3D-cultured 
IPCs. (E) Blood glucose levels of streptozotocin-induced diabetic nude mice changed to normoglycaemia 
levels after IPC transplantation (blue line, n = 4), whereas the sham mouse group (ochre line, n = 4) did not 
reach a normal range. Grey line shows blood glucose levels of naïve nude mice (n = 4). (F) Electron microscopy 
revealed dense cystic microstructures (left, upper row. Scale bar, 5 μm) and secretory granule-like structures 
(left, lower row. Scale bar, 0.2 μm) in the cytoplasm of 3D-cultured IPCs on day 21, resembling secretory 
granules observed in human naïve β-cells25 (right). White arrowhead: mature granules; black arrowhead: 
clathrin-coated secretory vesicles; arrow: condensing secretory material in a clathrin-coated Golgi cisterna. 
(G) RT-PCR analyses of SOX17, NGN3, and MAFA expression on days 0, 7. and 17 (*P < 0.01, **P < 0.001, 
Bonferroni’s test). (H) Immunohistochemistry of 3D-cultured IPCs on day 21 showed strong insulin expression 
(arrowhead). R, RCPγ piece. Scale bar, 25 μm.
Base line (pM) Low glucose (pM) High glucose (pM) SI
Conventional culture (2D, n = 3) 18.1 ± 2.0 7.5 ± 2.6 8.9 ± 2.7 1.2 ± 0.1
3D culture (n = 3) 16.4 ± 1.1 34.3 ± 22.5 129.9 ± 100.2 3.6 ± 0.9
Table 1. Insulin concentrations (pM) in culture medium supernatant. Note: all values are presented as the 
mean ± S.D.
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blood glucose levels of four mice decreased to under 200 mg/dl and were maintained below this level until 30 days 
after transplantation (4/4,100%), whereas the sham group (n = 4) could not convert their hyperglycaemic state to 
a normoglycaemia level (Fig. 1E).
3D-cultured IPCs contain secretory granules and secrete insulin. Electron microscopy showed 
insulin secretory granule-like structures and dense structures in 3D-cultured IPCs on day 21 as observed in 
human naïve β-cells as the control (Fig. 1F).
mRNA expression of differentiation marker genes in 3D-cultured IPCs. Expression of SOX17 as an 
endoderm development marker, of NGN3 as an endocrine cell differentiation marker, and of MAFA as an index 
of mature pancreatic β-cells, on day 17 were significantly higher compared with days 0 (SOX17, P < 0.01; NGN3 
and MAFA, P < 0.001, Bonferroni’s test, Fig. 1G) and day 7 (SOX17, P < 0.01; NGN3 and MAFA, P < 0.001, 
Bonferroni’s test, Fig. 1G).
Immunohistochemistry of IPCs showed strong insulin expression. To clarify the expression 
of insulin, IPCs were investigated using immunohistochemistry. The cytoplasm of IPCs in day 21 3D cultures 
stained strongly (especially granules-like structures) for insulin (Fig. 1H).
Dithizone stains IPCs gradually over time. In the 3D culture, the overall appearance of sphere-like for-
mations was gradually stained by dithizone (Fig. 2A, eight IPCs observed at each point). Representative images of 
four independent experiments are shown in Fig. 2A. Quantification of images of cultured cells by ImageJ26 showed 
that the staining intensity was gradually increased up to 180 and had statistically peaked on day 17 (P < 0.01, 
Bonferroni’s test) Based on three random points of eight IPCs, the average value is shown in Fig. 2B. After day 17, 
there were statistically no significant differences in the staining intensity of dithizone. As a reference, we evaluated 
the intensity in images of isolated human islets (Fig. 2A, right corner of the lower row), which was 244.
Zn2+ concentrations in culture medium change from negative to positive during proper IPC 
differentiation. Zn2+ concentration changes in the culture supernatants [ΔZn2+: calculated as Zn2+ (super-
natant) – Zn2+ (fresh culture medium)] of the 3D-cultured IPCs were measured and plotted. In the early period 
Figure 2. (A) Sphere-like formations containing ADSCs were gradually positively stained by dithizone every 
2 days during culture. Representative cell formations (n = 8 each time point) are shown. Freshly isolated 
human islets were included as a positive control (lower right corner). (B) Dithizone-stained cells were analysed 
by Image J. The staining intensity increased gradually and reached the peak on day 17. The average of three 
independent experiments is shown. *P < 0.01, Bonferroni’s test. Error bars represent the standard deviation. 
(C) Pattern of Zn2+ concentration changes in culture supernatants under 3D culture conditions. ΔZn2+  = Zn2+ 
(supernatant) − Zn2+ (fresh culture medium). Three independent experiments are shown as blue lines. Average 
SI at day 6, day 13 and day 21 are shown. Error bars represent the standard deviation. Grey-dotted line shows 
when cell culture failed to differentiate and mature properly because of the culture conditions. Average SI at day 
21 was showed. Error bars represent the standard deviation.
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of days 3 and 6, ΔZn2+ had a negative value. However, ΔZn2+ because positive from day 6 to 9 and reached its 
peak at day 13–17 (Blue lines in Fig. 2C, three independent experiments, SIs of each experiment were 2.64, 4.05, 
and 4.22, and the average SI was 3.64 at day 21, 0.86 at day 6, and 1.02 at day 13). However, if we failed to differen-
tiate and properly mature cells because of a lack of supplements, the increase of ΔZn2+ was low (grey-dotted line, 
Fig. 2C, average SI was 0.92 at day 21).
Zinc transporter expression in the early phase of the IPC differentiation protocol. ZIP4 expres-
sion was detected throughout the protocol, but reached its peak on day 7 and then decreased gradually (P < 0.05, 
vs day 21, Fisher’s least significant difference, Fig. 3A,B). However, ZnT8 expression was strongly detected from 
day 7 and then decreased significantly (P < 0.01, vs each point. P < 0.05, vs day 17, Fisher’s least significant dif-
ference, Fig. 3C,D).
Positive change pattern of the Zn2+ concentration might be specific, but a negative change 
pattern might be general in cells differentiated from ADSCs. ΔZn2+ of 3D-cultured IPCs reached 
its peak at day 13–17 as described above. However, ΔZn2+ in the conventional 2D culture had an obviously dif-
ferent pattern from that in the 3D culture, especially in the positive curve area (Fig. 4A). In the 3D culture, an 
increase of ΔZn2+ during day 7–21 was statistically correlated with the quantified intensity of dithizone staining 
(r = 0.798, Spearman’s rank correlation coefficient). To estimate the meaning of the negative curve area, the Zn2+ 
concentration changes were measured in the supernatant of hepatocyte-like cells (HLCs) cultured in differentia-
tion culture medium. Interestingly, the Zn2+ concentration change of culture supernatant in in early stage of the 
HLC differentiation protocol was also negative, and the positive curve pattern was different from that of IPCs in 
3D and 2D cultures (Fig. 4B).
Discussion
Islet transplantation is a β-cell replacement therapy that has the potential to make type 1 diabetes mellitus 
(T1DM) patients free of insulin injections. However, islet transplantation is still not widespread because of some 
issues. One of them is the severe donor shortage in some countries such as Japan1,27. Moreover, repeat transplanta-
tion is often required to achieve an insulin-free status, which accelerates the donor shortage. To resolve this issue, 
it is desirable to establish more stable and safe cell sources. Therefore, insulin-producing cells (IPCs) derived from 
mesenchymal stem cells are expected to be an alternative and non-cadaveric therapeutic cell source.
Figure 3. (A) Immunohistochemistry of ZIP4 at days 0, 7, 17, and 21. Representative results from three 
independent experiments are shown. (B) Staining intensities in images were measured by ImageJ. (C) 
Immunohistochemistry of ZnT8 at days 0, 7, 17, and 21. Representative results from three independent 
experiments are shown. (D) Staining intensities in images were measured by ImageJ. Three random fields 
were analysed. R: RCP petaloid μ-piece, *P < 0.05, **P < 0.01, Fisher’s least significant difference. Error bars 
represent the standard deviation.
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For clinical application of IPCs, cells function should be evaluated by a non-destructive procedure before 
transplantation. In previous methods including dithizone staining, RT-PCR, immunofluorescence staining, and 
western blotting, large numbers of IPCs must be sacrificed. It is well known that Zn2+ plays a critical role in insu-
lin release metabolism, and glucose stimulation induces Zn2+ release from islet cells28. Thus, we focused on the 
Zn2+ concentration because evaluation of the culture supernatant is a non-invasive method for cells. In this study, 
we found that the peak of dithizone staining intensity was day 17 and elevated differentiation marker expression. 
Interestingly, the staining intensity of generated IPCs approached that of human islets. However, as indicated 
by the SI, the generated IPCs had not completely achieved the same functions of human islets yet. Remarkably, 
ΔZn2+ did not reach statistical significance after day 17. Therefore, the maturation of IPCs might be adequate for 
transplantation earlier than day 21. Moreover, if we did not differentiate and mature IPCs properly because of the 
medium conditions, ΔZn2+ did not have a high enough positive value and a sufficient SI could not be achieved. 
These findings suggested that ΔZn2+ as an indicator of zinc ion dynamics in the culture medium reflected the 
IPC functional maturation status. Therefore, IPC transplantation on day 17 might produce interesting results.
However, the weekly increase in SI seemed to be different from that of zinc ion concentration in step 2. This 
observation suggested a discrepancy between the creation of insulin secretory granules and the acquisition of the 
ability to release insulin (ability to detect a change of glucose concentration), and this sensory ability might be 
obtained in the later phase of IPC differentiation.
Recently, Zn2+ transporters have been focused on for their roles in cells because Zn2+ is a functional com-
ponent in many cellular proteins and enzymes, and plays a key role in cell growth and development29–31. Zn2+ 
transporters include the zinc transporter protein (ZnT)/solute carrier 30A (SLC30A) family and Zrt, Irt-like 
protein (ZIP)/SLC39A family. Many reports indicate that the ZnT family carries Zn2+ from the cytoplasm to 
organelles or extracellular regions, while the ZIP family carries Zn2+ retrodirectionally21,30–32. Among them, ZnT8 
expression is detected mainly in insulin secretory granules33–35. Some T1DM cases are caused by an autoimmune 
disorder against ZnT836–41. In a recent study, ZnT8 expression was correlated with insulin secretion in rat islet 
cell line INS-1E42. In addition, it has also been reported that ZIP4 expression is associated with intake of Zn2+ by 
islet β cells43 and their differentiation and maturation44,45. In previous reports, stem cells have absorbed Zn2+ in 
their nuclei during differentiation46,47. In HLCs derived from ADSCs, we showed that ΔZn2+ values were neg-
ative in the early period of differentiation. This result suggest that ADSCs require a large amount of Zn2+ in the 
early stage of differentiation, at least for differentiation into endodermal cells, which is probably used to generate 
organelles and synthesise RNA47,48. Moreover, Zn2+ absorption appears to occur in embryonic stem cells during 
endoderm transition46,48. Therefore, based on our results above and previous reports, we predicted the mecha-
nism of Zn2+ changes during IPC differentiation (Fig. 5). Briefly, ADSCs start to generate insulin secretory gran-
ules after induction to endoderm and cell fate decision. To achieve these events, a large degree of RNA synthesis is 
required. Thus, ZIP4 performs an essential role for cell development44,45, which we named the “RNA synthesis and 
organelle generation phase” (Fig. 5 left). Then, along with increases of secretory granules, which contain insulin 
hexamers with two Zn2+ and ZnT834,35, the intensity of dithizone staining increases. After sufficient maturation, 
many secretory granules containing insulin and Zn2+ are gradually released from IPCs, resulting in an increase of 
the Zn2+ concentration, which we named the “secretory phase”.
Regarding the limitations of this study, there are some issues to be investigated further. First, essentially, 
there are no fixed evaluation methods for IPC differentiation and maturation. Thus, it is still unclear whether 
these IPCs differentiate and mature sufficiently. Second, in our study, marker gene expression was evaluated by 
RT-PCR only. Therefore, marker gene expressions should be confirmed by western blotting and immunostain-
ing. Similarly, zinc transporter protein expression was measured by immunohistochemistry only. By performing 
further experiments, the results of this study may confirm our hypothesis (Fig. 5). Third, during the differentia-
tion of stem cells, further analyses are required to understand zinc ion dynamics. According to our results from 
HLCs as another cell type, at least ADSCs require a large amount of Zn2+ to convert into cells of other germ 
Figure 4. (A) Comparison of the pattern of Zn2+ concentration changes in the culture supernatant of IPCs 
(n = 8 at each point) under 3D culture and 2D culture conditions, (B) or hepatocyte-like cell (HLC, n = 8 at 
each point) differentiation. Three independent experiments were performed. Error bars represent the standard 
deviation.
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layers such as endoderm and generate organelles. Zinc is essential and required for cell differentiation44,45. Thus, 
zinc ion dynamics might reflect cell fate decisions. Therefore, evaluating Zn2+ dynamics in the differentiation 
of other germ layer cells might support our hypothesis (Fig. 5). Fourth, the precise microstructures of IPCs are 
still unknown. We observed some undefined “empty granules” in 3D-generated IPCs by electron microscopy; 
however, further investigations are required to determine whether these structures are special IPCs structures or 
generated as a result of cell preparation or storage, or cell damage.
In conclusion, Zn2+ concentration changes in the culture supernatant might be a marker of IPC maturation. 
This new insight might be useful in validating the function of transplantable IPCs, excluding inadequate IPCs for 
transplantation, or monitoring production.
Materials and Methods
ADSC preparation. STEMPRO™ Human Adipose-Derived Stem Cells (Invitrogen, Grand Island, NY) 
were used in this study. ADSCs were cultured in ADSC basal medium consisting of MesenPROTM RS (Gibco, 
Carlsbad, CA) with GlutaMAXTM-I (Gibco).
IPC differentiation protocol. IPCs were generated as reported previously16,17. Briefly, after sufficient pas-
saging, ADSCs were mixed with recombinant peptide micro-pieces (RCP μ-pieces; FUJIFILM, Tokyo, Japan) 
and transferred to a Nunchlon Sphera 96U Bottom Plate (Thermo Scientific, Waltham, MA) for 3D culture. For 
conventional 2D culture, ADSCs without RCP μ-pieces were seeded into FALCON™ 6 Well Flat Bottom Tissue 
Culture Plate with a Low Evaporation Lid (Corning Co., Corning, NY). The protocol for IPC induction has 
Figure 5. ADSC started to generate insulin secretory granules after induction to endoderm-derived cells 
and fate decision. To achieve these events, mass RNA synthesis is required. Thus, it was considered that ZIP4 
was expressed and performed an essential role in cell development (“RNA synthesis and organelle generation 
phase”, left). Then, along with increases of secretory granules containing insulin hexamers with two Zn2+ each 
and expression of ZnT8, the intensity of dithizone staining was increased. After sufficient maturation, many 
secretory granules containing insulin and Zn2+ were gradually released from IPCs. Such release resulted in an 
increase of the Zn2+ concentration (“Secretory phase”, right).
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been reported previously18. However, the contents of the differentiation cocktail were changed to recombinant 
human activin-A, hepatocyte growth factor, and albumin. ADSCs were cultured using the step-1 (from day 0 to 
7) medium consisting of Dulbecco’s modified Eagle’s medium/F12 (Gibco) with 1% recombinant human albumin 
(Wako, Osaka, Japan), 10 nM exendin-4 (Sigma-Aldrich, St. Louis, MO), 1% N2 supplements (Gibco), 1% B27 
supplement (Gibco), and 50 ng/mL recombinant human activin-A (PeproTech, Rocky Hill, NJ). Step-2 (from 
day 8 to 21) medium was the same as step-1 medium with addition of 50 ng/mL recombinant human hepatocyte 
growth factor (PeproTech), valproic acid (Wako) and 10 mM nicotinamide (Sigma-Aldrich). The culture medium 
was changed and the supernatant was collected every 2 days.
Hepatocyte-like cell differentiation protocol. Hepatocyte-like cells (HLCs) were differentiated as 
reported previously49. Briefly, ADSCs were cultured using a 20-day differentiation protocol under 2D culture 
conditions. The differentiation protocol employed 2 μM Chir99021 (MedChemExpress, Monmouth Junction, 
NJ, USA), 1% ITS (Sigma-Aldrich), 20 ng/mL BMP2 (PeproTech), 30 ng/mL FGF4 (PeproTech), 20 ng/mL HGF 
(PeproTech), 10 ng/mL oncostatin M (PeproTech), and 10 μM dexamethasone (Sigma-Aldrich). Eight HLCs were 
investigated at each time point. Three independent experiments were performed for the cell analysis.
Glucose-stimulated insulin secretion test. A glucose-stimulated insulin secretion test was performed 
according to previous reports50–52. Briefly, differentiated cells were stimulated by 2.2 or 22 mM glucose in 
Krebs-Ringer’s solution for 1 hour at 37 °C in a 5% CO2 incubator. Krebs-Ringer’s solution consisted of 129 mM 
NaCl, 1.2 mM MgSO4, 1.2 mM KH2PO4, 4.7 mM KCl, 5 mM NaHCO3, 2.5 mM CaCl2, 10 mM HEPES, and 1% 
bovine serum albumin (Sigma-Aldrich). After stimulation, the supernatant of each sample was collected, and 
human insulin concentrations were measured by a Human/Canine/Porcine Insulin Quantikine ELISA Kit (R&D 
Systems, Minneapolis, MN). The optical absorbance was measured by a SpectraMax i3 (Molecular Devices, Sun 
Jose, CA) and SoftMax Pro 7 (Molecular Devices). The stimulation index (SI) was calculated as the ratio of the 
insulin measurement after 22 mM glucose stimulation divided by the insulin measurement after 2.2 mM glucose 
stimulation. Three independent experiments were performed to evaluate GSIS (n = 3).
Electron microscopy. Cells were prepared as reported previously17. Briefly, 3D-cultured IPCs were fixed 
in 0.1 M phosphate buffer with 2% paraformaldehyde and 2% glutaraldehyde at 4 °C overnight on day 21. After 
dehydration in graded ethanol solutions, the IPC samples were infiltrated by propylene oxide and resin (Nissin 
EM, Tokyo, Japan) for 1 hour. After transfer to fresh 100% resin, the IPC samples were polymerised at 60 °C for 
48 hours and then sectioned at 70 nm thicknesses using an ultramicrotome (Leica, Vienna, Austria). The sections 
were stained with 2% uranyl acetate at room temperature for 15 minutes. After washing with distilled water, the 
samples were secondary stained with a Lead stain solution (Sigma-Aldrich) at room temperature for 3 minutes. 
Electron microscopy was performed at Tokai Electron Microscopy Inc. (Nagoya, Japan). Sections were observed 
under a JEM-1400 Plus transmission electron microscope (JEOL Ltd. Tokyo, Japan) at an acceleration voltage of 
100 kV. Images were obtained by an EM-14830RUBY2 CCD camera (JEOL Ltd). As a control, we have included 
a human β-cell image obtained by electron microscopy (Fig. 1F, right, this image was reused in this study under 
an agreement with Elsevier25).
Dithizone staining. Cultured cells (n = 8, each day of the evaluation) were stained by a dithizone solution. 
The dithizone solution consisted of 50 mg dithizone (Wako) per 5 mL dimethyl sulfoxide (Wako). The IPCs were 
incubated in the dithizone solution at 37 °C with 5% CO2 after washing with PBS three times. The stained sam-
ples were assessed by a BZ-X710 multi-purpose microscope (KEYENCE Engineering, Tokyo, Japan) and BZ-X 
Analyzer (KEYENCE Software, Japan).
Zn2+ concentration assay. The culture supernatant was collected during medium changes. The Zn2+ con-
centration in each IPC sample was evaluated by a Metallo Assay kit zinc LS (Metallogenics Co., Chiba, Japan), 
according to manufacturer’s protocol. Briefly, 230 μl buffer, 12 μl sample, and 5 μl chelate colour solution were 
mixed and then transferred to a clear 96-well flat bottom plate (Corning Co.). Sample plates were analysed at 
560 nm optical absorbance. The Zn2+ concentration was determined according to the optical absorbance of the 
standard sample (200 mg/dl) and blank sample (deionised distilled water). Optical absorbance were measured by 
a SpectraMax i3 (Molecular Devices) and SoftMax Pro 7 (Molecular Devices). Each Zn2+ concentration change 
was calculated as: ΔZn2+  = Zn2+ (supernatant) − Zn2+ (fresh culture medium). Eight IPCs were investigated at 
each time point. Three independent experiments were performed for this assay (n = 3).
Immunohistochemical staining. IPC samples were fixed in formalin overnight and embedded in paraffin 
after embedding in iPGell (Genostaff, Tokyo, Japan). Four micrometre-thick sections of IPC samples and human 
kidney and pancreas (renal tubule cells and islets as negative and positive controls, respectively) were prepared. 
Usage of these resected specimens was approved by Tokushima University Hospital (Tokushima Clinical Trial 
Management System 2900-1, Dec 25, 2017). Specimen collection was performed in accordance with relevant 
guidelines/regulations. All patients had provided written informed consents. Sections were dewaxed, deparaffin-
ised in xylene (Wako), and rehydrated through a series of graded alcohol solutions. Endogenous peroxidases were 
blocked with 0.3% hydrogen peroxidase (Wako) for 20 minutes. For antigen retrieval, the sections were boiled 
in EDTA buffer (pH 6.0) using a microwave for 15 minutes at 1400 W and then for 10 minutes at 700 W. The sec-
tions were incubated in Protein Serum Free (Dako, Burlington, Canada) for 10 minutes to prevent nonspecific 
antigen binding. Samples were incubated with primary antibodies for 1.5 hours at room temperature. Primary 
antibodies were: anti-insulin (aa287-299, LS-B129; 1:100, LSBio, Seattle, WA), anti-human ZnT8 (16169-1-AP, 
1:50, Proteintech, Chicago, IL) and anti-human ZIP4 (20625-1-AP, 1:200, Proteintech). The sections were then 
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incubated with a secondary antibody (EnVision Dual Link System-HRP, DAKO) for 1 hour at room temperature. 
Sections were developed in diaminobenzidine (Wako) and counterstained with Mayer’s haematoxylin (Muto pure 
chemicals, Tokyo, Japan). The stained sections were dehydrated in graded alcohol solutions and coverslipped.
Immunofluorescence staining. Specimens of IPCs were sectioned, dewaxed, deparaffinised, and rehy-
drated. Blocking of endogenous peroxidases and retrieval of antigens were performed as described above. To 
prevent nonspecific antigen binding, the sections were incubated in 3% BSA for 1 hour. The sections were then 
incubated with an anti-human insulin antibody (#4590S, Cell Signaling Technology, Danvers, MA) as the pri-
mary antibody at 4 °C overnight. The sections were incubated with a secondary antibody, Alexa Fluor 555 goat 
anti-rabbit IgG (A-21244, 1:500, Invitrogen), after washing with PBS three times. Following washes with PBS, the 
sections were incubated with 4′,6-diamidino-2-phenylindole (28718-90-3, 1:2000, Santa Cruz Biotechnology, 
Paso Robles, CA) to detect nuclei. The stained samples were washed with PBS and coverslipped.
Quantitative imaging analysis. Images of cells were digitally analysed by ImageJ (National Institute of 
Health, Bethesda, ML)26. In the analysis of dithizone staining, images of cells were converted to hue, saturation 
and value (HSV) models and filtered by hue thresholds of 7–20. The mean grey value of saturation of three ran-
dom points in one spheroid area was measured in filtered images as the staining intensity52. In the analysis of 
immunohistochemical staining, after divided images into three channels, the images were filtered by hue thresh-
olds of 20–28. The mean grey value of saturation of three random points in one spheroid area and background 
were measured in filtered images. The staining intensity of immunohistochemistry was calculated as the ratio of 
the mean grey value in the spheroid area divided by that of the background. Staining intensity data were calcu-
lated as the average of eight cell spheres (three random points of IPCs, n = 8).
IPC transplantation into streptozotocin-induced diabetic nude mice. As an in vivo functional 
assay, transplantation of IPCs was undertaken as described in our previous report17. Briefly, 200 mg/kg body 
weight streptozotocin (STZ; Sigma-Aldrich) was dissolved in citrate buffer (pH 4.5) and administered to 5–6 
week-old BALB/c nude mice (Charles River Japan, Yokohama, Japan) by intraperitoneal injection. STZ-induced 
DM nude mice were defined as those with blood glucose values over 350 mg/dl for two continuous readings 
or 400 mg/dl in one reading. Ninety-six IPCs were transplanted into the mesentery of STZ-induced DM mice, 
according to our previous method for IPC transplantation17. Sham mouse group mice (n = 4, administered nor-
mal saline intra-mesentery) and naïve nude mouse group (n = 4) were included. After transplantation, blood 
glucose values obtained using a Medisafe Fit kit (TERUMO, Tokyo, Japan) and body weight were recorded every 
2 days, including sham and naïve nude mouse groups. All mice were bred in the animal facility at Tokushima 
University. Experiments and procedures were approved by the Animal Care and Use Committee of Tokushima 
University and performed in accordance with the NIH Guide for the Care and Use of Laboratory Animals.
Quantitative reverse transcription-polymerase chain reaction analyses. Total RNA was 
extracted from cultured cells with an RNeasy Mini Kit (QIAGEN, Hilden, Germany), according to the manu-
facturer’s instructions. RNA purity was assessed using a Nano Drop ND-1000 spectrometer (Thermo Scientific). 
cDNA was synthesised from total RNA using a reverse transcription kit (QIAGEN). Quantitative reverse 
transcription-polymerase chain reaction analysis was performed using TaqMan Gene Expression Assays in 7500 
real-time polymerase chain reaction system with StepOne Plus software (Applied Biosystems, Foster City, CA). The 
gene expression level was normalised to the GAPDH gene expression level. Primers for SOX17 (Hs00751752_s1, 
Applied Biosystems) and NGN3 (Hs01875204_s1, Applied Biosystems) were used in this study.
Statistical analysis. Statistical calculations were performed using SPSS statistics version 24 (IBM, Chicago, 
IL) or State Mate III (ATMS Co., LTD. Tokyo, Japan). Sample data were compared by the Mann-Whitney U-test, 
Student’s and Welch’s t-tests, or chi-squared test. Comparisons between multiple groups were performed by 
one-way ANOVA, Bonferroni’s test, and Fisher’s least significant difference. P-values of less than 0.05 were con-
sidered as significant.
Data availability
The datasets used and/or analysed in this study are available from the corresponding author upon reasonable 
request.
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